Menopause hormone therapy appears to guard against bone thinning in new study
A retrospective cohort study of 387 postmenopausal women presented at ENDO 2026 found those using menopausal hormone therapy had 69% lower odds of low bone mineral density than non-users (31.8% vs 56.2%), with higher lumbar spine and total hip T-scores, suggesting MHT may protect against osteoporosis. The study is observational and not peer‑reviewed, and regimens varied; risks such as uterine cancer, heart attack, stroke, and breast cancer should be weighed, with decisions individualized.
